Sergiusz Markowicz

Summary

Affiliation: Institute of Oncology
Country: Poland

Publications

  1. ncbi request reprint Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients
    Sergiusz Markowicz
    Department of Immunology, Maria Sklodowska Curie Memorial Institute and Oncology Centre, ul Roentgena 5, 02 781 Warszawa, Poland
    Med Oncol 29:2966-77. 2012
  2. ncbi request reprint A method for directly determining the number of dendritic cells and for evaluation of their function in small amounts of human peripheral blood
    S Markowicz
    The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    Arch Immunol Ther Exp (Warsz) 49:51-7. 2001
  3. ncbi request reprint Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapy
    S Markowicz
    The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland
    Cytokines Cell Mol Ther 7:15-24. 2002
  4. ncbi request reprint Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy
    Sergiusz Markowicz
    The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland
    Acta Biochim Pol 53:203-12. 2006
  5. ncbi request reprint Harnessing stem cells and dendritic cells for novel therapies
    Sergiusz Markowicz
    Department of Immunology, The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, 5 Roentgena St, 02 781 Warszawa, Poland
    Acta Pol Pharm 65:625-32. 2008
  6. ncbi request reprint The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes
    Magdalena Kowalewska
    Department of Molecular Biology, The Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Roentgena 5, 02 781 Warsaw, Poland
    Eur J Cancer 42:2671-4. 2006
  7. ncbi request reprint Opioid agonist--tachykinin antagonist as a new analgesic with adjuvant anticancer properties
    Joanna Matalinska
    Department of Neuropeptides, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland
    Folia Neuropathol 51:132-9. 2013
  8. doi request reprint Proteomics for development of vaccine
    Monika Adamczyk-Poplawska
    Department of Virology, Institute of Microbiology, Biology Faculty, Warsaw University, Warsaw, Poland
    J Proteomics 74:2596-616. 2011

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients
    Sergiusz Markowicz
    Department of Immunology, Maria Sklodowska Curie Memorial Institute and Oncology Centre, ul Roentgena 5, 02 781 Warszawa, Poland
    Med Oncol 29:2966-77. 2012
    ..Vaccinated patients had significantly longer OS after LND than the matched controls, but a significant improvement in the primary endpoint DFS was not achieved...
  2. ncbi request reprint A method for directly determining the number of dendritic cells and for evaluation of their function in small amounts of human peripheral blood
    S Markowicz
    The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    Arch Immunol Ther Exp (Warsz) 49:51-7. 2001
    ....
  3. ncbi request reprint Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapy
    S Markowicz
    The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland
    Cytokines Cell Mol Ther 7:15-24. 2002
    ..Our data show that numerical reconstitution of DC is not necessarily accompanied by functional recovery. The early recovery of DC should be considered while designing protocols for DC collection for immunotherapy...
  4. ncbi request reprint Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy
    Sergiusz Markowicz
    The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland
    Acta Biochim Pol 53:203-12. 2006
    ....
  5. ncbi request reprint Harnessing stem cells and dendritic cells for novel therapies
    Sergiusz Markowicz
    Department of Immunology, The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, 5 Roentgena St, 02 781 Warszawa, Poland
    Acta Pol Pharm 65:625-32. 2008
    ....
  6. ncbi request reprint The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes
    Magdalena Kowalewska
    Department of Molecular Biology, The Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Roentgena 5, 02 781 Warsaw, Poland
    Eur J Cancer 42:2671-4. 2006
    ....
  7. ncbi request reprint Opioid agonist--tachykinin antagonist as a new analgesic with adjuvant anticancer properties
    Joanna Matalinska
    Department of Neuropeptides, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland
    Folia Neuropathol 51:132-9. 2013
    ..Therefore, the compound should be considered as a new analgesic for treatment of cancer-related pains with adjuvant anticancer properties which may support cancer treatments...
  8. doi request reprint Proteomics for development of vaccine
    Monika Adamczyk-Poplawska
    Department of Virology, Institute of Microbiology, Biology Faculty, Warsaw University, Warsaw, Poland
    J Proteomics 74:2596-616. 2011
    ..Diverse aspects of disease mechanisms and disease preventions have been investigated by proteomics...